Innote (Tangshan) Biotechnology Co., Ltd.

Innotek (Tangshan) Biotechnology Co., Ltd. has six major technology platforms, including colloidal gold, PCR, enzyme-linked and chemiluminescence. Currently we have obtained more than 20 invention patents. Innotek has now successfully registered the nine-in-one joint test for respiratory tract (Mycoplasma pneumoniae/Chlamydia pneumoniae/influenza A/influenza B/parainfluenza/syncytial virus/adenovirus/Coxsackie family B/Legionella pneumophila IgM 9-in-1 combined detection reagent) (indirect immunofluorescence), and the five joint test for respiratory tract (Mycoplasma pneumoniae/Chlamydia pneumoniae/syncytial virus/adenovirus/Coxsackie family B) IgM The 5-in-1 combined detection reagent (colloidal gold) and respiratory triple detection (influenza A / B / parainfluenza IgM 3-in-1 combined detection reagent) (colloidal gold) can simultaneously detect IgM antibodies to nine/five/three major respiratory pathogens. It fills a gap in China. Innotek launched a special international scientific and technological cooperation project in the key R&D projects of Hebei Province in 2018 - an influenza A virus gene detection and typing kit jointly developed by ParaDNA instruments and Hybeacon probe technology. Innotek is currently cooperating with many major domestic hospitals and has been exported to more than 100 countries around the world.